Clozapine toxicity in smoking cessation and with ciprofloxacin

Psychosomatics. Mar-Apr 2008;49(2):176. doi: 10.1176/appi.psy.49.2.176.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Antipsychotic Agents / pharmacokinetics
  • Antipsychotic Agents / therapeutic use
  • Antipsychotic Agents / toxicity*
  • Ciprofloxacin / pharmacokinetics
  • Ciprofloxacin / therapeutic use
  • Ciprofloxacin / toxicity*
  • Clozapine / pharmacokinetics
  • Clozapine / therapeutic use
  • Clozapine / toxicity*
  • Cytochrome P-450 CYP1A2 / biosynthesis
  • Cytochrome P-450 CYP1A2 Inhibitors
  • Cytochrome P-450 CYP3A / biosynthesis
  • Cytochrome P-450 CYP3A Inhibitors
  • Drug Interactions
  • Enzyme Induction / drug effects
  • Humans
  • Inactivation, Metabolic
  • Male
  • Middle Aged
  • Myocarditis / blood
  • Myocarditis / chemically induced
  • Myocarditis / diagnosis
  • Psychotic Disorders / blood
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / psychology
  • Risk Factors
  • Smoking Cessation*
  • Substance Withdrawal Syndrome / blood
  • Substance Withdrawal Syndrome / diagnosis*
  • Substance Withdrawal Syndrome / psychology
  • Urinary Tract Infections / blood
  • Urinary Tract Infections / drug therapy*

Substances

  • Antipsychotic Agents
  • Cytochrome P-450 CYP1A2 Inhibitors
  • Cytochrome P-450 CYP3A Inhibitors
  • Ciprofloxacin
  • Cytochrome P-450 CYP1A2
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human
  • Clozapine